Ten Chinese government departments, including the Ministry of Industry and Information Technology and the National Development and Reform Commission, jointly released the "15th Five-Year Plan for the Development of the Pharmaceutical Industry." The plan mandates accelerating the integration of artificial intelligence, quantum computing, supercomputing, and computational medicine to empower drug research and development through interdisciplinary collaboration among enterprises, universities, and medical institutions.
The initiative explores novel production models such as beyond-limit manufacturing, space pharmaceuticals, and biomanufacturing. It also targets breakthroughs in frontier technologies including gene editing, precise molecular delivery, cell programming, next-generation brain-computer interfaces, and xenotransplanted organs to cultivate new industry growth points.
China Unveils 15th Five-Year Pharma Plan Integrating AI and Quantum Computing for Drug R&D
免責事項: Phemexニュースで提供されるコンテンツは、あくまで情報提供を目的としたものであり、第三者の記事から取得した情報の正確性・完全性・信頼性について保証するものではありません。本コンテンツは金融または投資の助言を目的としたものではなく、投資に関する最終判断はご自身での調査と、信頼できる専門家への相談を踏まえて行ってください。
